Lee Hugar, MD
Urology · West Columbia, SCNPI 1790199636
Payments from drug & device makers
Across 45 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$311
- Sumitomo Pharma America, Inc.$130
- Calyxo, Inc.$114
- Intuitive Surgical$98
- Olympus America Inc.$79
- Urogen Pharma, Inc.$68
- plus $261 from 11 others
What the payments were for
- Food & beverage$1,062100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 19 | $311 |
| Sumitomo Pharma America, Inc. | 6 | $130 |
| Calyxo, Inc. | 1 | $114 |
| Intuitive Surgical | 1 | $98 |
| Olympus America Inc. | 2 | $79 |
| Urogen Pharma, Inc. | 3 | $68 |
| Innovation Technologies Inc | 2 | $65 |
| AbbVie | 2 | $33 |
| Merck | 1 | $31 |
| 180 Medical, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $19 |
| Progenics Pharmaceuticals, Inc. | 1 | $17 |
| Endo USA, Inc. | 1 | $16 |
| Procept Biorobotics Corporation | 1 | $15 |
| Novartis | 1 | $15 |
| Ambu Inc. | 1 | $15 |
| Laborie Medical Technologies Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,062 in reported general payments places this provider in the 30th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 66 | $44,821 |
| Tamsulosin Hcl | 296 | $4,084 |
| Finasteride | 269 | $3,997 |
| Potassium Citrate ErPotassium Citrate | 19 | $1,607 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 78 | $1,217 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $420 |
| Oxybutynin Chloride | 44 | $315 |
| Ciprofloxacin Hcl | 101 | $206 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $95 |
| Methocarbamol | 32 | $90 |
| Fluconazole | 11 | $63 |
| Ibuprofen | 29 | $38 |
| Diazepam | 42 | $34 |
Paid to pharmacies, not to this prescriber.
Other urology in West Columbia
- Thomas WillardWest Columbia$79K
- Phillip WestbrookWest Columbia$14K
- Griffin MorrissonWest Columbia$14K
- Keith BrightbillWest Columbia$12K
- Scott SweazyWest Columbia$8K
- John BeasleyWest Columbia$8K
- David LambWest Columbia$7K
- Neal ShoreMyrtle Beach$63.3M
- Sandip PrasadCharleston$2.4M
- Stephen SavageCharleston$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.